1.54 USD
▲0.00+1.99%
盘后 1.52 +0.66%
2026-08-03
市值
$170.98M
市盈率
—
EPS
-1.19
股息率
—
52 周区间
1.09 – 3.40
成交量
407.15K
Beta
0.60
目标价
3.10
52W 低 1.0952W 高 3.40
价格走势
公司简介
Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer’s disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson’s disease and Lewy body...